Clinical Trial Update: Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-transporter 2 Inhibitor to Gliclazide Modified Release

View source ↗

Summary

This clinical trial update reports real-world effectiveness and patient insights when adding a sodium-glucose cotransporter 2 (SGLT2) inhibitor to gliclazide mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gliclazide Modified Release (gliclazide)
• SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: Servier Affaires Médicales | Conditions: Type 2 Diabetes | Status: COMPLETED